Data / Research funding / Illinois / Rosalind Franklin Univ of Medicine & Sci
Rosalind Franklin Univ of Medicine & Sci: 40 NIH awards ($33.1M) and 1 NSF award ($159K), fiscal years 2021 to 2026
Rosalind Franklin Univ of Medicine & Sci in North Chicago, IL is funded under 40 NIH awards ($33.1M) and 1 NSF award ($159K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- V913TCT2SFZ9
- State
- Illinois
Awards
41 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| The Integrated Role of Vasopressin and Oxytocin Receptors in the Modulation of BNST Activity and Fear Processing | NIH | National Institute of Mental Health | 2021 to 2025 | $2,290,237 | May 12, 2017 | May 31, 2027 | DABROWSKA, JOANNA | reporter.nih.gov |
| A longitudinal and experience sampling investigation of rejection sensitivity and its role in sexual minority adolescents' mental health | NIH | National Institute of Mental Health | 2023 to 2025 | $2,257,292 | May 1, 2023 | July 31, 2028 | FEINSTEIN, BRIAN | reporter.nih.gov |
| Parallel maturation of social behaviors and amygdala circuits | NIH | National Institute of Mental Health | 2021 to 2025 | $2,241,392 | March 1, 2019 | June 30, 2029 | ROSENKRANZ, JEREMY E | reporter.nih.gov |
| Mechanisms of stimulus-induced network focusing | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,899,300 | April 15, 2021 | March 31, 2027 | FROST, WILLIAM | reporter.nih.gov |
| Reading Frame Correction for the Treatment of Batten Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,746,388 | May 1, 2020 | May 15, 2023 | HASTINGS, MICHELLE L | reporter.nih.gov |
| Role of non-myeloid cells' pyroptosis in melioidosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,505,790 | March 17, 2023 | February 29, 2028 | RE, FABIO C | reporter.nih.gov |
| Positive allosteric modulator PNU-120596 to treat HIV-associated neurocognitive disorders | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,356,796 | June 1, 2024 | March 31, 2029 | HE, JOHNNY J | reporter.nih.gov |
| Structure and mechanism of the mitochondrial ATP synthase and Batten Disease gene product, Cln3p | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,334,132 | August 1, 2019 | July 31, 2025 | MUELLER, DAVID MICHAEL | reporter.nih.gov |
| Molecular Basis of Substrate Translocation in the Drug/H+ Antiporter 1 Family | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,310,400 | June 15, 2022 | April 30, 2026 | LU, MIN | reporter.nih.gov |
| Molecular regulation of TLR2-mediated autoimmune inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,170,000 | November 15, 2018 | October 31, 2025 | REYNOLDS, JOSEPH MICHAEL | reporter.nih.gov |
| The contribution of perivascular adipose tissue macrophages to microvascular dysfunction in obesity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,116,800 | January 19, 2019 | December 31, 2024 | WHITE, CARL | reporter.nih.gov |
| Role of neurexin in social adaptation and amygdala plasticity | NIH | National Institute of Mental Health | 2024 to 2025 | $1,056,714 | August 5, 2024 | March 31, 2029 | ROSENKRANZ, JEREMY E | reporter.nih.gov |
| Role of TAM receptors in modulating humoral immunity against parasitic infections | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,041,618 | September 5, 2024 | August 31, 2029 | VIJAY, RAHUL | reporter.nih.gov |
| Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,013,596 | April 1, 2019 | January 31, 2024 | STEINER, HEINZ | reporter.nih.gov |
| Molecular Basis of Coats Plus Disease | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $910,185 | January 1, 2023 | December 31, 2026 | CHAI, WEIHANG | reporter.nih.gov |
| Improving Diabetic Foot Ulcer Offloading: A Pilot Study on the Impact of Removable Cast Walker Design Factors on Usability | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $837,374 | August 1, 2022 | May 31, 2026 | ROSENBLATT, NOAH | reporter.nih.gov |
| Neural circuits for decision making | NIH | National Institute of Mental Health | 2023 to 2024 | $780,000 | April 13, 2023 | March 31, 2026 | HWANG, EUN JUNG | reporter.nih.gov |
| The sex specific impact of anxiety on Alzheimer's disease progression | NIH | National Institute on Aging | 2022 to 2024 | $747,000 | April 1, 2022 | March 31, 2026 | HUNSBERGER, HOLLY CHRISTIAN | reporter.nih.gov |
| Effect of Menthol to Non-Menthol Cigarette Switching on Subclinical Inflammatory Biomarkers of Cardiovascular Health: Simulating a Menthol Cigarette Ban | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $710,856 | September 1, 2022 | June 30, 2027 | JAO, NANCY CHIA LEI | reporter.nih.gov |
| Reprogramming Cell Fate for Repair | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $551,979 | June 15, 2017 | May 31, 2023 | PETERSON, DANIEL ALAN | reporter.nih.gov |
| Molecular modulator of RAD51 in maintaining genome stability | NIH | National Cancer Institute | 2023 to 2025 | $503,830 | December 1, 2019 | December 31, 2029 | CHAI, WEIHANG | reporter.nih.gov |
| Pharmacological inhibition of NEP-like enzymes in traumatic brain injury and dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $434,225 | May 15, 2024 | April 30, 2027 | MARR, ROBERT ANTHONY | reporter.nih.gov |
| Selective targeting of CNS cells in vivo for multiple transgene delivery and neuronal reprogramming | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $434,225 | February 20, 2024 | March 31, 2026 | PETERSON, DANIEL ALAN | reporter.nih.gov |
| Homeostatic regulation of CaV2 voltage-gated calcium channels at synapses | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $434,225 | June 7, 2024 | May 31, 2026 | KIM, HONGKYUN | reporter.nih.gov |
| Intracellular organelle deficits driving Alzheimer's disease | NIH | National Institute on Aging | 2024 | $431,155 | September 1, 2020 | August 31, 2025 | STUTZMANN, GRACE E. | reporter.nih.gov |
| Generation of Parkinson-derived human glial progenitor cells for dopaminergic neuronal conversion | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $429,925 | June 1, 2024 | May 31, 2026 | PETERSON, DANIEL ALAN | reporter.nih.gov |
| The development of gene therapeutic approaches to suppress cerebral inflammation in dementia | NIH | National Institute on Aging | 2022 | $429,000 | September 1, 2022 | August 31, 2025 | MARR, ROBERT ANTHONY | reporter.nih.gov |
| Studies on Probenecid Prodrugs that Protect against Mitochondrial Toxicity of Tenofovir | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $429,000 | August 1, 2022 | July 31, 2024 | BUOLAMWINI, JOHN K | reporter.nih.gov |
| Improving vaccination against type-2 T-independent antigens | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $428,304 | December 1, 2023 | October 31, 2026 | RE, FABIO C | reporter.nih.gov |
| Utilizing gene-level biomarkers of AD to identify pathophysiological mechanisms in human neurons | NIH | National Institute on Aging | 2023 | $422,645 | August 15, 2023 | July 31, 2025 | STUTZMANN, GRACE E. | reporter.nih.gov |
| The role of mitochondrial stress response in alcohol-mediated neurotoxicity | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2023 | $409,500 | September 25, 2022 | August 31, 2025 | KIM, HONGKYUN | reporter.nih.gov |
| Anti-nucleolin aptamer AS1411: Applications in Kaposi's Sarcoma Associated Herpes Virus (KSHV) biology | NIH | National Cancer Institute | 2023 to 2024 | $401,115 | January 1, 2023 | December 31, 2025 | SHARMA-WALIA, NEELAM | reporter.nih.gov |
| Developing Selective Inhibitors and Probes for Concentrative Nucleoside Transporters | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $383,327 | August 1, 2024 | June 30, 2027 | BUOLAMWINI, JOHN K | reporter.nih.gov |
| The role of inhibitory microcircuits in the neural control of breathing | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $341,250 | December 1, 2016 | November 30, 2022 | KAM, KAIWEN | reporter.nih.gov |
| A genetic study of BK channel trafficking and regulation in C. elegans | NIH | National Institute of General Medical Sciences | 2021 | $337,107 | January 1, 2018 | December 31, 2022 | KIM, HONGKYUN | reporter.nih.gov |
| Understanding and reducing HIV risk behavior and substance use among self-identified bisexual adolescent men | NIH | National Institute on Drug Abuse | 2021 to 2022 | $332,078 | November 3, 2020 | December 31, 2023 | FEINSTEIN, BRIAN | reporter.nih.gov |
| Identification of a novel tumor suppressor of melanoma and UV-induced genome instability | NIH | National Institute of Environmental Health Sciences | 2023 | $236,850 | March 20, 2024 | June 30, 2025 | CHAI, WEIHANG | reporter.nih.gov |
| Summer Research Fellowship Program for Podiatric Medical Students | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $223,143 | September 1, 2008 | April 30, 2029 | ROSENBLATT, NOAH | reporter.nih.gov |
| Graduate Research Fellowship Program (GRFP) | NSF | Scholarships, Fellowships, and Traineeships Section | 2024 | $159,000 | August 15, 2024 | July 31, 2029 | Brian Feinstein | nsf.gov |
| A longitudinal investigation of intersectional discrimination, alcohol use outcomes, and underlying mechanisms among bisexual people of color | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 | $69,150 | September 30, 2023 | August 31, 2024 | RENTERIA, ROBERTO | reporter.nih.gov |
| Impact of social drive on social fear learning and amygdala function during development | NIH | National Institute of Mental Health | 2021 | $66,199 | September 16, 2019 | August 31, 2022 | FERRARA, NICOLE CHRISTINE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $53,000 |
| 2025 | 17 | $6,401,944 | 1 | $53,000 |
| 2024 | 23 | $8,663,250 | 1 | $53,000 |
| 2023 | 22 | $7,233,884 | 0 | $0 |
| 2022 | 17 | $5,526,151 | 0 | $0 |
| 2021 | 14 | $5,228,873 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Neurosciences
- Brain Disorders
- Genetics
- Behavioral and Social Science
- Mental Health
- Neurodegenerative
- Basic Behavioral and Social Science
- Infectious Diseases
- Pediatric
- Acquired Cognitive Impairment
- Rare Diseases
- Dementia
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.